Eterna Therapeutics Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Eterna Therapeutics Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q2 2024.
  • Eterna Therapeutics Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$5.53M, a 22.6% decline year-over-year.
  • Eterna Therapeutics Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$23.9M, a 10.1% decline year-over-year.
  • Eterna Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$21.7M, a 11.8% increase from 2022.
  • Eterna Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$24.6M, a 79.9% increase from 2021.
  • Eterna Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$123M, a 1581% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$23.9M -$5.53M -$1.02M -22.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$22.9M -$6.65M -$1.23M -22.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$21.7M -$6.15M -$1.66M -37% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 -$20M -$5.59M +$1.73M +23.6% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 -$21.7M -$4.51M -$1.11M -32.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$20.6M -$5.42M +$3.96M +42.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 -$24.6M -$4.49M +$3.46M +43.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 -$28M -$7.32M +$78.7M +91.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$107M -$3.4M +$6.69M +66.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 -$113M -$9.38M +$9.15M +49.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$123M -$7.95M -$5.73M -258% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-20
Q3 2021 -$117M -$86M -$84M -4156% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$32.8M -$10.1M -$8.05M -396% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$24.8M -$18.5M -$17.5M -1717% Jan 1, 2021 Mar 31, 2021 10-Q 2022-07-01
Q4 2020 -$7.29M -$2.22M -$925K -71.6% Oct 1, 2020 Dec 31, 2020 10-K/A 2022-07-01
Q3 2020 -$6.37M -$2.02M -$1.67M -476% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$4.7M -$2.03M -$1.94M -2159% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 -$2.75M -$1.02M -$706K -226% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$2.05M -$1.29M -$1.35M -2587% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-11
Q3 2019 -$702K -$351K -$573K -258% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 -$129K -$90K +$34K +27.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$163K -$313K +$96K +23.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-20
Q4 2018 -$259K $52K +$691K Oct 1, 2018 Dec 31, 2018 10-K 2020-03-19
Q3 2018 -$950K $222K +$406K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-01
Q2 2018 -$1.36M -$124K +$40K +24.4% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-12
Q1 2018 -$1.4M -$409K -$319K -354% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 -$1.08M -$639K -$180K -39.2% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-22
Q3 2017 -$897K -$184K +$389K +67.9% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 -$1.29M -$164K +$686K +80.7% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-06
Q1 2017 -$1.97M -$90K +$951K +91.4% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
Q4 2016 -$2.92M -$459K +$531K +53.6% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-09
Q3 2016 -$3.45M -$573K +$775K +57.5% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 -$4.23M -$850K +$1.78M +67.6% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-04
Q1 2016 -$6M -$1.04M +$1.22M +54% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 -$7.23M -$990K +$728K +42.4% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-09
Q3 2015 -$7.95M -$1.35M -$33K -2.51% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$7.92M -$2.63M -$1.28M -94.7% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 -$6.64M -$2.26M -$1.61M -249% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 -$5.03M -$1.72M -$1.37M -389% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-15
Q3 2014 -$3.66M -$1.32M -$1.08M -462% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 -$2.58M -$1.35M -$1.25M -1262% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 -$1.33M -$649K -$280K -75.9% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 -$1.05M -$351K -$980K -156% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-27
Q3 2013 -$73K -$234K -$288K -533% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 $215K -$99K +$534K +84.4% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 -$319K -$369K +$676K +64.7% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 -$995K $629K +$1.67M Oct 1, 2012 Dec 31, 2012 10-K 2013-03-29
Q3 2012 -$2.66M $54K +$891K Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 -$3.55M -$633K +$351K +35.7% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 -$3.91M -$1.05M -$486K -86.9% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-13
Q4 2011 -$3.42M -$1.04M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-29
Q3 2011 -$837K -$961K -775% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-29
Q2 2011 -$984K -$527K -115% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-29
Q1 2011 -$559K Jan 1, 2011 Mar 31, 2011 10-K 2013-03-29
Q3 2010 $124K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 -$457K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.